Litigation: SEC Obtains Final Judgment Against Ex-CFO Charged With Fraud and Lying to Auditors
March 22, 2023
March 22, 2023
WASHINGTON, March 22 -- The Securities and Exchange Commission issued the following litigation release (No. 17-cv-03230-SAG; D. Md. filed Nov. 2, 2017) involving Philip R. Jacoby, Jr., et al.:
* * *
On March 17, 2023, the U.S. District Court for the District of Maryland entered a final consent judgment against Philip R. Jacoby, a former Chief Financial Officer of biotech company Osiris Therapeutics, Inc., for his role in Osiris's fraudulent conduct.
The SEC . . .
* * *
On March 17, 2023, the U.S. District Court for the District of Maryland entered a final consent judgment against Philip R. Jacoby, a former Chief Financial Officer of biotech company Osiris Therapeutics, Inc., for his role in Osiris's fraudulent conduct.
The SEC . . .